WINNETKA, Calif., Dec. 10, 2014 /PRNewswire/ -- Green Cures
& Botanical Distribution Inc. (OTC Pink: GRCU) ("Green Cures")
a cannabis and industrial hemp products innovator is pleased to
announce the launching of CBDOil.us, the first product review and
potency verification online platform for CBD-derived products in
the U.S. market today. Management of Green Cures stated that
CBDOil.us is the first online platform, where the online community
will be able to learn about the potency and consistency of numerous
CBD-derived/infused products that are currently being marketed and
sold nationally in the U.S. Through each of the product review
sections, which include CBD potency reports that have been
conducted by certified U.S. Laboratories, the consumers, the
public, and the investment community can learn about the CBD
potency level in a product of their interest, and compare these
potency levels to those being advertised by the different CBD
product manufacturers and brands currently in the market.
"It also important to note that in accordance with federal
guidelines, imported CBD-rich oil extracted from industrial hemp
cannot exceed a level of Tetrahydrocannabinol (THC) higher than
.3%," commented Green Cures CEO Robert
Calkin.
Management of Green Cures invited both the consumers and product
manufacturers to upload their certified CBD potency reports to
CBDOil.us, so that the online community can learn more about the
products that they have either purchased or introduced to the
market.
Additionally, the company announced the immediate availability
of its one fluid ounce of CBD Tincture by Green Cures containing
100 mg of CBD-rich oil. CBD Tincture by Green Cures is exclusively
available through allcbd.com, which is one of the company's
e-commerce platforms, where online consumers can purchase
CBD-derived products from anywhere across the U.S., as permitted by
law. CBD Tinctures by Green Cures (100 mg) are currently being
offered in two different flavors, natural and strawberry. At the
same time, the company informs to the public and the investment
community that a potency report for the latest Tincture has been
uploaded to allcbd.com. This report has been conducted on behalf of
the company by a certified laboratory in the state of California. According to the new report, the
CBD Tinctures by Green Cures offer 3.91 milligrams of infused CBD
oil per milliliter; one fluid ounce contains 29.6 milliliters of
infused oil.
As stated in previous releases, numerous properties and benefits
of CBD are being investigated at academic research centers in
the United States and
elsewhere. The FDA has not evaluated the validity or
truthfulness of these claims. As such, Green Cures management
encourages its customers and the market in general to review the
published research relating to the benefits and properties of CBD
hemp oils and other CBD infused products, and to educate themselves
on the use and benefits of these oils and products. Green
Cures management will continue to monitor research results relating
to the benefits and properties of CBD hemp oils and other products
as well.
In closing, the company will provide additional updates as they
become available.
About Green Cures & Botanical Distribution Inc.: Green Cures
& Botanical Distribution Inc. is a development stage company
that retails and wholesales nutritional, sports, hemp-infused and
body care products. The company is currently Web-based and focuses
on online retailing. Green Cures & Botanical Distribution Inc.,
operates a diverse portfolio of products and services within the
botanical and cannabis industry, as permitted by law. From concept
to production and distribution, Green Cures & Botanical
Distribution Inc., is continuously creating and introducing
products that promote a healthy life style.
www.gcbdinc.com
FDA Statement: The statements contained in this document have
not been evaluated or approved by the FDA. The products and
statements referenced in this document are not intended to
diagnose, treat, cure, or prevent any disease.
Forward-looking statement: This press release may contain
certain forward-looking statements and information, as defined
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, and is subject
to the Safe Harbor created by those sections. This material
contains statements about expected future events and/or financial
results that are forward-looking in nature and subject to risks and
uncertainties. Forward-looking statements are identified by wording
such as "scheduled (future sense)" "intend(s)", "plan(s)"
"expect(s)", "believe(s)" "will" "estimate(s)", "anticipate(s)",
"expect(s)", "may", "would", "could" or "should" or, in each case,
the negative thereof, other variations thereon, or comparable
terminology that implies anticipated future deliverables. The
Company disclaims any obligation or intention to update any
forward-looking statement for any reason.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/green-cures-and-botanical-distribution-inc-announces-the-launching-of-cbdoilus-and-the-addition-of-new-products-to-the-line-green-cures-containing-a-minimum-of-100mg-of-infused-cbd-oil-300007532.html
SOURCE Green Cures & Botanical Distribution Inc.